Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015
Cancer Research and Treatment · 15.01.2023 · 55 (1) · 103-111
DOI: 10.4143/crt.2022.264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.01.2023. Verfasst von Da Som Jeon und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
This study aimed to provide the clinical characteristics, prognostic factors, and 5-year relative survival rates of lung cancer diagnosed in 2015.Materials and Methods The demographic risk factors of lung cancer were calculated using the KALC-R (Korean Association of Lung Cancer Registry) cohort in 2015, with survival follow-up until December 31, 2020. The 5-year relative survival rates were estimated using Ederer II methods, and the general population data used the death rate adjusted for sex and age published by the Korea Statistical Information Service from 2015 to 2020.
Results
We enrolled 2,657 patients with lung cancer who were diagnosed in South Korea in 2015. Of all patients, 2,098 (79.0%) were diagnosed with non–small cell lung cancer (NSCLC) and 345 (13.0%) were diagnosed with small cell lung cancer (SCLC), respectively. Old age, poor performance status, and advanced clinical stage were independent risk factors for both NSCLC and SCLC. In addition, the 5-year relative survival rate declined with advanced stage in both NSCLC (82%, 59%, 16%, 10% as the stage progressed) and SCLC (16%, 4% as the stage progressed). In patients with stage IV adenocarcinoma, the 5-year relative survival rate was higher in the presence of epidermal growth factor receptor (EGFR) mutation (19% vs. 11%) or anaplastic lymphoma kinase (ALK) translocation (38% vs. 11%).
Conclusion
In this Korean nationwide survey, the 5-year relative survival rates of NSCLC were 82% at stage I, 59% at stage II, 16% at stage III, and 10% at stage IV, and the 5-year relative survival rates of SCLC were 16% in cases with limited disease, and 4% in cases with extensive disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Hospital Pathology, Yeouido St. Mary's hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Zitieren
APA
Jeon, D. S., Kim, H. C., Kim, S. H., Kim, T. J., Kim, H. K., Moon, M. H., Beck, K. S., Suh, Y. G., Song, C., Ahn, J. S., Lee, J. E., Lim, J. U., Jeon, J. H., Jung, K. W., Jung, C. Y., Cho, J. S., Choi, Y. D., Hwang, S. S., Choi, C. M., …, & Korea Central Cancer Registry (2023). Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer Research and Treatment, 55(1), 103-111. https://doi.org/10.4143/crt.2022.264
Vancouver
Jeon DS, Kim HC, Kim SH, Kim TJ, Kim HK, Moon MH, et al. Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer Research and Treatment. 2023;55(1):103-111. doi:10.4143/crt.2022.264
BibTeX
@article{Jeon2023,
author = {Jeon, Da Som and Kim, Ho Cheol and Kim, Se Hee and Kim, Tae-Jung and Kim, Hong Kwan and Moon, Mi Hyung and Beck, Kyongmin Sarah and Suh, Yang-Gun and Song, Changhoon and Ahn, Jin Seok and Lee, Jeong Eun and Lim, Jeong Uk and Jeon, Jae Hyun and Jung, Kyu-Won and Jung, Chi Young and Cho, Jeong Su and Choi, Yoo-Duk and Hwang, Seung-Sik and Choi, Chang-Min and Korean Association for Lung Cancer, Korean Association for Lung Cancer and Korea Central Cancer Registry, Korea Central Cancer Registry},
title = {Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015},
journal = {Cancer Research and Treatment},
year = {2023},
volume = {55},
number = {1},
pages = {103--111},
doi = {10.4143/crt.2022.264}
}
EUVIMED